Acute and subchronic effects of bilastine (20 and 40mg) and hydroxyzine (50mg) on actual driving performance in healthy volunteers.

Trial Profile

Acute and subchronic effects of bilastine (20 and 40mg) and hydroxyzine (50mg) on actual driving performance in healthy volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2012

At a glance

  • Drugs Bilastine; Hydroxyzine
  • Indications Allergic rhinitis; Rhinoconjunctivitis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top